NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS - 01 JUNE 2016

CS NIFTY FUTURES (JUNE) OVERVIEW

TREND MIXED TO BULLISH

RES2:8275

RES 1:8250     

SUP1:8155

SUP2:8105

CS BANK NIFTY FUTURES (JUNE) OVERVIEW

TREND MIXED TO BULLISH

RES 2:17755

RES 1:17675

SUP1:17310

SUP2:17275

                           

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

CS AGRI CALL: SELL GUARSEED 01 JUNE 2016

CS  AGRI CALL: SELL GUAR SEED JUNE BELOW 3085 

TG :- 3065/3045/3025 

SL :- 3115

                                            

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

CS PRECIOUS CALL: SELL SILVER 01 JUNE 2016

CS  PRECIOUS CALL: SELL SILVER JULY BELOW 38340 

TG :-38140/37940/37740 

SL:- 38540

                                

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

TOP CORPORATE NEWS - 31 MAY 2016

Sun Pharma drops on lower than expected Q4FY16 profit

Shares of Sun Pharma dropped 6% to Rs760 on NSE as the Q4FY16 profit was lower than expectation due to forex loss (in Taro); Buyback expectations could support valuations in the near term.

India sales at Rs1, 807 crores, up by 17% over Q4 last year.

US finished dosage sales at US$ 580 million up by 19% over Q4 last year. US sales include the benefit of the 180-day exclusivity for gGleevec which commenced from 01-Feb-2016.

Emerging Markets sales at US$ 124 million. Rest of World sales at US$ 79 million.

R&D investments at Rs711 crore, 9.6% of net sales

EBITDA at Rs2, 300 crore, resulting EBITDA margin of 31%.

Net profit for the quarter was at Rs1, 714 crore.

Bata India Q4: Net Profit -52.2% at Rs27.9 Cr

Bata India Q4: Net Profit -52.2% at Rs 27.9 Cr Vs Rs 58.4 Cr (YoY)

Total Income +10.9% at Rs 545.7 Cr Vs Rs 491.3 Cr

EBITDA +17.9% At Rs 55.3 Cr vs Rs 46.9 Cr (YoY)

EBITDA Margin At 10.2% Vs 9.5% (YoY)

L&T's arm enters into agreement with Parsons

Leading Engineering & Construction Company, L&T Hydrocarbon Engineering (LTHE) has announced that it has entered into a teaming agreement with Parsons to provide engineering and design solutions for onshore and offshore projects across the hydrocarbon, fertilizer, chemicals, and modular plant sectors.

LTHEs' broad range of offerings across the hydrocarbon spectrum coupled with Parsons' strong program management capabilities in the Americas will provide a compelling value proposition to our customers.

SAIL Q4: Net Loss at Rs1, 230.9 Cr Vs Profit of Rs334.2 Cr (YoY)

SAIL Q4: Net Loss at Rs1, 230.9 Cr Vs Profit of Rs334.2 Cr (YoY)

EBITDA Loss at Rs 1,123.4 Cr Vs EBITDA Profit Of Rs 10,914 Cr (YoY)

Total Income -1.9% at Rs 11,371.7 Cr Vs Rs 11,590.6 Cr (YoY)

GAIL starts drilling 2nd exploratory well at Cambay basin

GAIL (India) Ltd has said that it has started drilling its second exploratory well as an operator in its New Exploration Licensing Policy – IX block at the Cambay Basin.

The well is situated in the Nabhoi village in Tarapur Tehsil of Anand District in Gujarat. The ‘spudding’ operations started on May 27.

The first well was spud in this block on March 27. Drilling of a target depth of 2,200 meters of this well is scheduled to be completed in 30 to 35 days.

                                       

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

CS CLOSING BELL: 31 MAY 2016

CS CLOSING BELL:

NIFTY SPOT DOWN 17@ 8160

SENSEX DOWN 57@ 26667

BANK NIFTY FUTURES UP 10@ 17517

HAVE A NICE DAY!

                                            

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

CS ENERGY CALL: BUY CRUDE OIL 31 MAY 2016

CS  ENERGY CALL: BUY CRUDE OIL JUNE  ABOVE 3350 

TG :-3400/3450/3500

SL:- 3280

                                    

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

CS OPENING BELL: 31 MAY 2016

CS OPENING BELL:

NIFTY SPOT UP 13@8191

SENSEX UP45@26772

BANK NIFTY FUTURES UP 30@ 17537

HAPPY TRADING

                              

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

TOP CORPORATE NEWS - 30 MAY 2016

NTPC Q4: Net Profit at Rs2, 716 Cr

NTPC Q4: Net Profit at Rs.2, 716 Cr Vs Rs.2, 944 Cr (YoY)

Other Income at Rs.448 Cr Vs Rs.570.7 Cr (YoY)

Total Income -6.2% at Rs.18, 113 Cr Vs Rs.19, 309 Cr (YoY)

EBITDA +15.7% at Rs.5, 458 Cr Vs Rs.4, 719 Cr (YoY)

EBITDA Margin At 30.1% Vs 24.5% (YoY)

M&M Standalone Net Profit +6% at Rs583.7 Cr Vs Rs550.6 Cr (YoY)

M&M Standalone Net Profit +6% at Rs583.7 Cr Vs Rs550.6 Cr (YoY)

Standalone Total Income +14.5% at Rs.10, 800 Cr Vs Rs.9, 434.4 Cr (YoY)

Standalone Other Income at Rs.111.7 Cr Vs Rs.89.6 Cr (YoY)

Standalone EBITDA +16.5% at Rs.1, 049 Cr Vs Rs.900.5 Cr (YoY)

Standalone EBITDA Margin At 9.7% Vs 9.5% (YoY).

Sun Pharma gets US subpoena over generic drugs pricing

Sun Pharma gets US subpoena over generic drugs pricing – Sentimental Negative for Sun; the inquiry is unlikely to have any adverse impact on the consolidated operations or consolidated financial results of the company.

The US Department of Justice (DoJ) has subpoenaed Sun Pharmaceutical Industries seeking information about the pricing and marketing of the generic drugs it sells in the United States.

The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors.

Reliance Infra net profit up 44% to Rs660 crore (YoY)

Reliance Infrastructure has announced the following results for the quarter & year ended March 31, 2016

Standalone

For the Quarter ended March 31, 2016

The Company has posted a net profit of Rs728.95 crore Vs Rs449.97 crore.

Total Income is Rs3291.08 crore Vs Rs3179.59 crore.

Hindalco Inds Q4 net profit at Rs356 cr

Hindalco Industries has announced the following Q4 & FY16 results for the quarter & year ended March 31, 2016

Standalone:

For the Quarter ended March 31, 2016

The Company has posted a net profit of Rs356.33 crore Vs Rs159.53 crore.

Total Income is Rs8871.66 crore Vs Rs9601.63 crore.

Berger Paints Q4: Cons Net Profit +59.7% at Rs92.8 Cr

Berger Paints Q4: Cons Net Profit +59.7% at Rs.92.8 Cr Vs Rs.58.1 Cr (YoY)

To Issue Bonus of 2 Shares for Every 5 Held

Cons Total Income +8.6% at Rs.1, 130 Cr Vs Rs.1040.3 Cr (YoY)

Cons EBITDA +31.7% at Rs.159.3 Cr Vs Rs.121 Cr (YoY)

Cons EBITDA Margin At 14.1% Vs 11.6% (YoY)

                                 

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

CS CLOSING BELL: 30 MAY 2016

CS CLOSING BELL:

NIFTY SPOT UP 21@ 8178

SENSEX UP 72@ 26725

BANK NIFTY FUTURES UP 7@ 17500

HAVE A NICE DAY!

                                      

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

CS OPENING BELL: 30 MAY 2016

CS OPENING BELL:

NIFTY SPOT UP 25@8182

SENSEX UP79@26742

BANK NIFTY FUTURES UP 125@ 17617

HAPPY TRADING

                                    

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More

TOP CORPORATE NEWS - 27 MAY 2016

IOC Q4 Net Profit comes at Rs1,236 Cr

IOC Q4 Net Profit comes at Rs1, 236 Cr

Total Income at Rs.80, 449.7 Cr

EBITDA at Rs.10, 044 Cr

EBITDA Margin At 5%

GRM At $3/bbl Vs $6/bbl (QoQ)

Canara Bank Q4: Net Loss at Rs3,905 Cr

Canara Bank Q4: Net Loss at Rs3, 905 Cr

Gross NPA At 9.4% Vs 5.84% (QoQ)

Gross NPA +59.7% at Rs.31, 638 Cr Vs Rs.19, 813 Cr (QoQ)

Net NPA At 6.42% Vs 3.90% (QoQ)

Tax Write-back At Rs.779.5 Cr Vs Expense of Rs.110 Cr (YoY)

Provisions at Rs.6, 331 Cr Vs Rs.1, 429 Cr (QoQ)

NII -4.5% at Rs.2, 374 Cr Vs Rs.2, 486 Cr (YoY)

SBI Q4FY16: Mixed Bag performance, Asset quality worsens

State Bank of India Q4FY16 results first cut: Mixed Bag performance

SBI Q4: Net Profit -66.2% At Rs.1,264 Cr Vs Rs.3,742 Cr (YoY)

Gross NPA +34.9% At Rs.98,172 Cr Vs Rs.72,791 Cr (QoQ)

Gross NPA At 6.5% Vs 5.1% (QoQ)

Net NPA At 3.81% Vs 2.89% (QoQ)

Net NPA +38.7% At Rs.55,807 Cr Vs Rs.40,249 Cr (QoQ)

Slippages At Rs.30,312 Cr Vs Rs.20,692 Cr (QoQ)

Provisions For NPA At Rs.12,139.2 Cr Vs Rs.7,644.6 Cr (QoQ)

Lupin gains on receiving EIR for Mandideep facility

Shares of Lupin gained 3% to Rs1507 on NSE on back of reports that the company has got Establishment Inspection Report (EIR) for its Mandideep facility.

This is sentimentally positive for Lupin; stock is up by 3%; USFDA clearance for Goa plant will be key to watch for going forward.

Torrent Pharma in talks to buy Glochem Industries for Rs300 crore

Torrent Pharma in talks to buy Glochem Industries for Rs300 crore – Long term positive for Torrent if deal goes thru

Torrent Pharma is in advanced talks to buy bulk drugs supplier Glochem Industries for about Rs300 crore.

Glochem is a medium-sized company that makes bulk drugs, or active ingredients, which are used as raw material for medicines and has USFDA approved sites in Hyderabad and Vizag where oral bulk actives are manufactured.

                                

Get real time advice for Intraday Trading Tips , Share Market Live  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Read More